Association of longevity with IL‐10 −1082 G/A and TNF‐α−308 G/A polymorphisms
暂无分享,去创建一个
[1] K. Koh,et al. Counter-stress effects of relaxation on proinflammatory and anti-inflammatory cytokines , 2008, Brain, Behavior, and Immunity.
[2] Tamara Cacev,et al. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. , 2008, Carcinogenesis.
[3] R. Lipton,et al. Adiponectin levels and genotype: a potential regulator of life span in humans. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.
[4] C. Franceschi,et al. A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.
[5] C. Franceschi,et al. The immune system in extreme longevity , 2008, Experimental Gerontology.
[6] N. Schork,et al. Successful Aging: From Phenotype to Genotype , 2007, Biological Psychiatry.
[7] R. May. Gender, immunity and the regulation of longevity. , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.
[8] J. Satoh,et al. Association of TNF-α Gene Promoter C-857T Polymorphism with Higher Serum LDL Cholesterol Levels and Carotid Plaque Formation in Japanese Patients with Type 2 Diabetes , 2007 .
[9] C. Falcone,et al. Inflammation and Atherosclerosis: The Role of TNF and TNF Receptors Polymorphisms in Coronary Artery Disease , 2007, International journal of immunopathology and pharmacology.
[10] A. Cayuela,et al. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis , 2006, Critical care.
[11] C. Caruso,et al. Inflammation, Longevity, and Cardiovascular Diseases , 2006, Annals of the New York Academy of Sciences.
[12] W. Griffin,et al. Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.
[13] J. Edelberg,et al. PDGF-AB-based functional cardioprotection of the aging rat heart , 2006, Experimental Gerontology.
[14] C. Franceschi,et al. Genes, ageing and longevity in humans: Problems, advantages and perspectives , 2006, Free radical research.
[15] C. Franceschi,et al. Study of the Association with −330T/G IL-2 in a Population of Centenarians from Centre and South Italy , 2005, Biogerontology.
[16] Joon-Yong Park,et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. , 2005, Cancer letters.
[17] T. Kirkwood. Time of our lives , 2005 .
[18] Serkalem Demissie,et al. Disentangling the genetic determinants of human aging: biological age as an alternative to the use of survival measures. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[19] C. Franceschi,et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians , 2005, Mechanisms of Ageing and Development.
[20] C. Franceschi,et al. Aging, Longevity, Inflammation, and Cancer , 2004, Annals of the New York Academy of Sciences.
[21] Claudio Franceschi,et al. The G/C915 polymorphism of transforming growth factor β1 is associated with human longevity: a study in Italian centenarians , 2004, Aging cell.
[22] C. Franceschi,et al. Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)γ-2 with longevity , 2004, Experimental Gerontology.
[23] L. Ferrucci,et al. Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians , 2004, Aging clinical and experimental research.
[24] H. Bruunsgaard,et al. Inflammatory mediators in the elderly , 2004, Experimental Gerontology.
[25] Snejina Michailova,et al. Immunological markers contributing to successful aging in Bulgarians , 2004, Experimental Gerontology.
[26] C. Franceschi,et al. The −174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing , 2004, Experimental Gerontology.
[27] C. Franceschi,et al. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 −1082 promoter SNP and its interaction with TNF-α −308 promoter SNP , 2003, Journal of medical genetics.
[28] C. Caruso,et al. IL-10 and TNF-α polymorphisms in a sample of sicilian patients affected by tuberculosis: implication for ageing and life span expectancy , 2003, Mechanisms of Ageing and Development.
[29] Claudio Franceschi,et al. The role of IL-1 gene cluster in longevity: a study in Italian population , 2003, Mechanisms of Ageing and Development.
[30] C. Franceschi,et al. Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population , 2002, Genes and Immunity.
[31] L Scola,et al. Gender-specific association between −1082 IL-10 promoter polymorphism and longevity , 2002, Genes and Immunity.
[32] Claudio Franceschi,et al. Allele frequencies of +874T→A single nucleotide polymorphism at the first intron of interferon-γ gene in a group of Italian centenarians , 2002, Experimental Gerontology.
[33] M. Jylhä,et al. Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-α genes in Finnish nonagenarians , 2001, Mechanisms of Ageing and Development.
[34] B. Weir,et al. Sex-specific longevity associations defined by Tyrosine Hydroxylase–Insulin–Insulin Growth Factor 2 haplotypes on the 11p15.5 chromosomal region , 2001, Experimental Gerontology.
[35] C. Franceschi,et al. A gender–dependent genetic predisposition to produce high levels of IL‐6 is detrimental for longevity , 2001, European journal of immunology.
[36] A. Bateman,et al. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma , 2001, Genes and Immunity.
[37] C. Dinarello,et al. Proinflammatory cytokines. , 2000, Chest.
[38] A. Hajeer,et al. TNF‐α gene polymorphism: Clinical and biological implications , 2000 .
[39] J. Bidwell,et al. CYTOKINE GENE POLYMORPHISM , 2000 .
[40] F. Pociot,et al. Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.
[41] P. Woo,et al. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[42] N. Makhatadze. Tumor necrosis factor locus: genetic organisation and biological implications. , 1998, Human immunology.
[43] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] L. Abraham,et al. The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .
[45] C. Brayne,et al. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. , 1997, Atherosclerosis.
[46] M. Lazarus,et al. An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[47] George Murray,et al. Longevity , 1886, The Hospital.
[48] J. Satoh,et al. Association of TNF-alpha gene promoter C-857T polymorphism with higher serum LDL cholesterol levels and carotid plaque formation in Japanese patients with type 2 diabetes. , 2007, The Tohoku journal of experimental medicine.
[49] T. Kirkwood. Time of our lives. What controls the length of life? , 2005, EMBO reports.
[50] M. Rose-Zerilli,et al. Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis , 2005, Familial Cancer.
[51] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[52] A. Hajeer,et al. TNF-alpha gene polymorphism: clinical and biological implications. , 2000, Microscopy research and technique.
[53] S. Khoury,et al. Mortality and causes of death in Jordan 1995-96: assessment by verbal autopsy. , 1999, Bulletin of the World Health Organization.
[54] L. Abraham,et al. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. , 1997, Molecular immunology.